CD48 Antibody, anti-human, PE-Vio® 770, REAfinity™ 130-106-469 from Miltenyi Biotec | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
Miltenyi Biotec for
CD48 Antibody, anti-human, PE-Vio® 770, REAfinity™

Miltenyi Biotec's CD48 Antibody, anti-human, PE-Vio® 770, REAfinity™ is a Human monoclonal antibody. The CD48 Antibody, anti-human, PE-Vio® 770, REAfinity™ was generated using CD48 as the antigen. It reacts with Human. This antibody has been shown to work in applications such as: Flow Cytometry.

Product Specs
ItemCD48 Antibody, anti-human, PE-Vio® 770, REAfinity™
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-106-469
Regulatory StatusFor research use only
ApplicationsFlow Cytometry (FCM)
Concentration1:11
ModificationsRecombinantly engineered
Research AreaFor research use only
ReactivityHuman (Hu)
Clonalitymonoclonal
NCBI Gene AliasesBCM1, BLAST, BLAST1, MEM-102, SLAMF2, hCD48, mCD48
NCBI Full Gene NameCD48 molecule
Antibody TypePrimary antibodies, Recombinant antibodies
Hosthuman cell line
CloneREA426
IsotypeIgG1
TargetCD48
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
Conjugate/TagPE-Vio 770
Quantity100 tests in 1 mL

Add to Compare List

Miltenyi Biotec

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1) Characterization and activity of Fas ligand producing CD5⁺ B cellsMethods in molecular biology (Clifton, N.J.)January 1, 2014Lundy SK, Klinker MW.

(2) CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylationLeukemiaMay 1, 2010Efanov A, Zanesi N, Nazaryan N, Santanam U, Palamarchuk A, Croce CM, Pekarsky Y.

(3) A role for CD5 in TCR-mediated signal transduction and thymocyte selectionScience (New York, N.Y.)July 28, 1995Tarakhovsky A, Kanner SB, Hombach J, Ledbetter JA, Müller W, Killeen N, Rajewsky K.

Be the First to Write a Review!